Embed Size (px)
DESCRIPTION
Â
Citation preview
IAH Products and R&D Pipeline as at March 2015
Feeds and Supplements
Horse Feeds
Horse Fertility Feeds
Equine Performance Supplements
Technology IAH Approved Trials Underway Data Completed Regulatory Pathway On Market
ENA Global Yes N/R Completed CompletedN/R N/R Yes
TPM™ AUS Yes N/R Completed CompletedN/R N/R Yes
TPM™ Global Yes Yes Completed Completed APVMA N/R Yes
Dairy Feed Inclusion Technologies
Dairy Inclusion Technology
Dairy Feed Fertility Technology
Dairy Embryo Transfer Fertility Technology
TPM™ AUS NZ UAE Yes N/R Completed CompletedN/R N/R Yes
MMA Global Yes Completed CompletedN/R N/R Yes
MMA Global Yes N/R 2015
Dairy Calf Immune Booster MMA Global Yes N/R 2015
N/R
N/R
Ethics Approval Pre ClinicalLicense
For all Out-License and In-License Enquiries:Blake Hawley | President and CEO of the Americas | [email protected]
Rob Neely | Chief Executive Officer | [email protected]
Other Feed Inclusion Technologies
Beef Cattle & Dairy LWG FIT
Poultry & Swine LWG FIT
Aquaculture LWG FIT
Think Fly Global Yes N/R UnderwayN/R 2015
TPM™ Pending N/R N/R
TPM™ Pending N/R
TPM™ Drug Delivery Technology
Oxycodone Patch (Equine) TPM™ Global Yes Yes Completed CompletedCompleted FDA
2015
N/R 2015
2017
Drug Delivery Topical
NSAID Companion Animals Other Global Yes Yes UnderwayCompleted 2016
Companion Animals Think Fly Yes N/R N/R 2015Global Underway
FDA
Technology IAH Approved Trials Underway Data Completed Regulatory Pathway On MarketEthics Approval Pre ClinicalLicense
For all Out-License and In-License Enquiries:Blake Hawley | President and CEO of the Americas | [email protected]
Rob Neely | Chief Executive Officer | [email protected]
Parasiticides
Topical / Transdermal
Companion Animals
Undisclosed Global Yes Yes
Undisclosed Global Yes N/R 2016
2016
Peptides
Vaccines
Undisclosed Project Partner Undisclosed Global Yes Required 2017
Technology IAH Approved Trials Underway Data Completed Regulatory Pathway On MarketEthics Approval Pre ClinicalLicense
For all Out-License and In-License Enquiries:Blake Hawley | President and CEO of the Americas | [email protected]
Rob Neely | Chief Executive Officer | [email protected]
Dairy & Swine Embryology
Chemical Spermatozoa X Y Selection Technology
Undisclosed Global Yes Yes Underway 2015
Pathology App
Undisclosed Project Partner
Undisclosed Project Partner
IT Global Yes N/R
Undisclosed Global Pending Required
2015
Bone & Soft Tissue Technology
N/R
2017
Swine Embyro Transfer Fertility Technology
Undisclosed Global Yes N/R 2015
Yes
Technology IAH Approved Trials Underway Data Completed Regulatory Pathway On MarketEthics Approval Pre ClinicalLicense
For all Out-License and In-License Enquiries:Blake Hawley | President and CEO of the Americas | [email protected]
Rob Neely | Chief Executive Officer | [email protected]
Equine Non-swabbable nutraceuitcals Undisclosed Global Pending
Inflammation Reduction
2016
Companion Animals Undisclosed Global Pending 2016
Technology IAH Approved Trials Underway Data Completed Regulatory Pathway On MarketEthics Approval Pre ClinicalLicense
For all Out-License and In-License Enquiries:Blake Hawley | President and CEO of the Americas | [email protected]
Rob Neely | Chief Executive Officer | [email protected]
About Integrated Animal Health Pty Ltd
Integrated Animal Health (IAH) is a privately owned and funded Australian company. IAH began by developing World First Animal Health products based on the patented human TPM® Delivery Technology, which delivers nutraceuticals and also drugs both orally and through the skin. Notably, in 2014, IAH delivered Oxycodone in a World First via a TPM®/Oxycodone topical patch to provide quick pain relief to thoroughbred racehorses with shin soreness.
Integrated Animal Health is now known for its unique ability to identify early stage disruptive technology. IAH is now developing and trialing over 70 products including a natural oral tick and fly repellents for use in the cattle feedlot industry with companion animals to follow. They are also working on non-mechanical X/Y Sperm selection technology for the Hog and Dairy industries.
Integrated Animal Health's core strategy has been to identify difficult to deliver compounds that have already demonstrated safety and efficacy in humans and to develop non-therapeutics for feed chain animals, companion animals or performance animals around the world. One of their biggest commercial achievements to date has been a natural application that has shown to decrease antibiotic use by 50% in clinical mastitis in dairy cows, such is the importance of this technology IAH are now in commercial discussions with several Top 10 Global Dairy Companies.
Integrated Animal Health's business model is to out-license and partner its technologies for separate species and territories globally.
Mastitis Management Australia, Equine Ergogenics Australia and Veterinary Research Australia amalgamated to become Integrated Animal Health in December 2013 and incorporated February 2014.
For all Out-License and In-License Enquiries:
Blake HawleyPresident and CEO of the Americas
Rob NeelyChief Executive Officer
www.integrated-animal-health.com
